Evidence map›Paper›PMID 41904131›Full record

ArticleNature communications2026

Phosphorylation of SF3B1 by CDK11 orchestrates spliceosome activation via SNIP1-dependent RES complex recruitment.

Pavla Gajdušková, Igor Ruiz de Los Mozos, Milan Hluchý, Antonina Myšková, Kateřina Zábrady, Peter Maník, Neda Dragišić, Kateřina Hanáková, David Potěšil, Sara Bologna and 5 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Targeting CDKs in the RNAPII transcription cycle.Nature reviews. Drug discovery · 2026
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Pavla Gajdušková *Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
Igor Ruiz de Los Mozos *Department of Personalized Medicine, NASERTIC, Government of Navarra, Pamplona, Spain.ORCID http://orcid.org/0000-0003-4097-6422
Milan HluchýCentral European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
Antonina MyškováCentral European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
Kateřina ZábradyCentral European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
Peter ManíkCentral European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
Neda DragišićCentral European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
Kateřina HanákováCentral European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.ORCID http://orcid.org/0000-0001-9575-8866
David PotěšilCentral European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.ORCID http://orcid.org/0000-0003-0390-0904
Sara BolognaCentral European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.ORCID http://orcid.org/0000-0002-2709-8322
Jiří NováčekCentral European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.ORCID http://orcid.org/0000-0003-4013-3898
Caroline C FriedelInstitute for Informatics, LMU Munich, Munich, Germany.ORCID http://orcid.org/0000-0003-3569-4877
Konstantinos TripsianesCentral European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.ORCID http://orcid.org/0000-0003-0948-813X
Zbyněk ZdráhalCentral European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
Dalibor BlazekCentral European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic. dalibor.blazek@ceitec.muni.cz.ORCID http://orcid.org/0000-0003-4662-9982

Funding

Grantová Agentura České Republiky (Grant Agency of the Czech Republic) 23-04754X
6 · The paper itself

Abstract

Splicing Factor 3b Subunit 1 (SF3B1), a core component of the spliceosome, undergoes dynamic phosphorylation and dephosphorylation during the splicing cycle to regulate pre-mRNA splicing. Twenty-eight threonine/proline repeats are phosphorylated by CDK11 during spliceosome activation and remain phosphorylated in the catalytically active spliceosomes. The function of phosphorylated SF3B1 (P-SF3B1), and the identity of spliceosomes stalled by CDK11 inhibition remain unclear. Using quantitative proteomics of chromatin-associated spliceosomes, we identify a previously uncharacterized intermediate complex B

Indexed as

Cyclin-Dependent KinasesPhosphoproteinsRNA Splicing FactorsSpliceosomesHeLa CellsHumansPhosphorylationRNA PrecursorsRNA SplicingCDK11a protein, humanCyclin-Dependent KinasesPhosphoproteinsRNA PrecursorsRNA Splicing FactorsSF3B1 protein, human

Identifiers

PMID41904131
PMCPMC13194972

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.